• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Future Pak withdraws offer to buy Vanda Pharmaceuticals

cafead

Administrator
Staff member
  • cafead   Jun 27, 2024 at 11:52: AM
via Contract manufacturer Future Pak said on Wednesday it has withdrawn its offer to acquire Vanda Pharmaceuticals (VNDA.O) citing non-engagement from the U.S. drugmaker.

article source